These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2079657)

  • 1. Effect of aminomethyl (N-Mannich base) derivatization on the ability of S6-acetyloxymethyl-6-mercaptopurine prodrug to deliver 6-mercaptopurine through hairless mouse skin.
    Saab AN; Sloan KB; Beall HD; Villaneuva R
    J Pharm Sci; 1990 Dec; 79(12):1099-104. PubMed ID: 2079657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: S6-acyloxymethyl-6-mercaptopurine prodrugs.
    Waranis RP; Sloan KB
    J Pharm Sci; 1988 Mar; 77(3):210-5. PubMed ID: 3373424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of 6-mercaptopurine (6-MP) with N-alkyl-N-alkoxycarbonylaminomethyl chlorides: S6-(N-alkyl-N-alkoxycarbonyl)aminomethyl-6-MP prodrug structure effect on the dermal delivery of 6-MP.
    Siver KG; Sloan KB
    J Pharm Sci; 1990 Jan; 79(1):66-73. PubMed ID: 2313580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs.
    Waranis RP; Sloan KB
    J Pharm Sci; 1987 Aug; 76(8):587-95. PubMed ID: 11002816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs.
    Sloan KB; Wasdo S; Ezike-Mkparu U; Murray T; Nickels D; Singh S; Shanks T; Tovar J; Ulmer K; Waranis R
    Pharm Res; 2003 Apr; 20(4):639-45. PubMed ID: 12739773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen.
    Wasdo SC; Sloan KB
    Pharm Res; 2004 Jun; 21(6):940-6. PubMed ID: 15212157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.
    Roberts WJ; Sloan KB
    J Pharm Sci; 2003 May; 92(5):1028-36. PubMed ID: 12712422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs.
    Beall HD; Sloan KB
    Int J Pharm; 2002 Jan; 231(1):43-9. PubMed ID: 11719012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical delivery of N-alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) prodrugs of theophylline (ThH).
    Majumdar S; Sloan KB
    Int J Pharm; 2007 Mar; 332(1-2):64-71. PubMed ID: 17064862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Alkylcarbonyloxymethyl prodrugs of 5-fluorouracil (5-FU): synthesis, physicochemical properties, and topical delivery of 5-FU.
    Taylor HE; Sloan KB
    J Pharm Sci; 1998 Jan; 87(1):15-20. PubMed ID: 9452962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model.
    Roberts WJ; Sloan KB
    J Pharm Sci; 2000 Nov; 89(11):1415-31. PubMed ID: 11015687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.
    Majumdar S; Mueller-Spaeth M; Sloan KB
    AAPS PharmSciTech; 2012 Sep; 13(3):853-62. PubMed ID: 22648150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrugs of 6-thiopurines: enhanced delivery through the skin.
    Sloan KB; Hashida M; Alexander J; Bodor N; Higuchi T
    J Pharm Sci; 1983 Apr; 72(4):372-8. PubMed ID: 6683309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.
    Beall HD; Sloan KB
    Int J Pharm; 2001 Apr; 217(1-2):127-37. PubMed ID: 11292549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Mannich-base prodrugs of 5-iodo-2'-deoxycytidine as topical delivery enhancers.
    Koch SA; Sloan KB
    Pharm Res; 1987 Aug; 4(4):317-20. PubMed ID: 3508538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach.
    Roberts WJ; Sloan KB
    J Pharm Sci; 1999 May; 88(5):515-22. PubMed ID: 10229642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing for topical delivery: prodrugs can make the difference.
    Sloan KB; Wasdo S
    Med Res Rev; 2003 Nov; 23(6):763-93. PubMed ID: 12939791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery.
    Thomas JD; Majumdar S; Sloan KB
    Molecules; 2009 Oct; 14(10):4231-45. PubMed ID: 19924060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of alkylcarbonyloxymethyl (ACOM) ethers as novel prodrugs of phenols for topical delivery: ACOM prodrugs of acetaminophen.
    Thomas JD; Sloan KB
    Int J Pharm; 2008 Jan; 346(1-2):80-8. PubMed ID: 17629641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of alkyloxycarbonyloxymethyl (AOCOM) ethers as novel prodrugs of phenols for topical delivery: AOCOM prodrugs of acetaminophen.
    Thomas JD; Sloan KB
    Int J Pharm; 2009 Apr; 371(1-2):25-32. PubMed ID: 19136050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.